Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-paclitaxel + cisplatin + 5-FU versus paclitaxel + cisplatin + 5-FU for induction chemotherapy in locally advanced head and neck squamous cell carcinoma
ChiCTR2100041869Phase 4Recruiting
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of paclitaxel, cisplatin and fluorouracil in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by Zhejiang Provincial People's Hospital. Primary endpoint: complete response. Started Jun 2019; status: recruiting.
02
Drugs
paclitaxelcisplatinfluorouracil
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on ChiCTR2100041869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100041869.